Actively Recruiting
Effectiveness and Safety of Early Intramuscular Botulinum Toxin Injections to Prevent Shoulder Deformity in Babies With Obstetrical Brachial Plexus Palsy
Led by University Hospital, Brest · Updated on 2026-03-20
62
Participants Needed
7
Research Sites
471 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In children population with obstetrical brachial plexus palsy (OBPP), shoulder musculoskeletal deformity is the main cause of morbidity, with a loss of range of shoulder motion, pain and a reduction in social participation. Some uncontrolled studies shows that early injections of botulinum toxin (BTI) in the internal shoulder rotator muscles (which cause the deformity) are one of the most promising treatment for the prevention of bony deformity. The main objective of this study will be the evaluation of the effectiveness of BTI in the internal shoulder rotator muscles at the age of 12 months in preventing an increase in posterior subluxation of the glenohumeral joint in babies with OBPP (evaluated at the ages of 11 months and 18 months), compared to the Sham group.
CONDITIONS
Official Title
Effectiveness and Safety of Early Intramuscular Botulinum Toxin Injections to Prevent Shoulder Deformity in Babies With Obstetrical Brachial Plexus Palsy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male and female babies with unilateral OBPP
- Age between 10 and 11 months
- Presenting one of 2 risk factors for posterior subluxation of the humeral head (10° less passive external ROM of the affected shoulder compared with the contralateral shoulder and/or a score strictly less than 6 on the AMS for shoulder external rotation and abduction, elbow flexion or supination)
- Signature of the consent form by (the) parent(s) over the age of majority
You will not qualify if you...
- Bilateral OBPP
- Microsurgery or secondary muscle surgery planned between 12 and 18 months of age
- Contraindications to the use of botulinum toxin
- Contraindications to MRI
- MRI not possible in the Paediatric Day Hospital setting because of contraindications to the sedation protocol or due to organisational constraints
- Parents inapt to provide consent for the participation of their child
- Parents under the age of 18 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 7 locations
1
CHRU Brest
Brest, France, 29609
Actively Recruiting
2
Institut Régionnal de Réadaptation Centre de Réadaptation pour enfant
Flavigny-sur-Moselle, France, 54630
Not Yet Recruiting
3
ESEAN (Etablissement de Santé pour Enfants et Adolescents de la région Nantaise)
Nantes, France
Not Yet Recruiting
4
CHU Nîmes
Nîmes, France, 30029
Actively Recruiting
5
CHU Rennes
Rennes, France, 35033
Actively Recruiting
6
CHU St Etienne
Saint-Etienne, France, 42055
Not Yet Recruiting
7
Hôpital national de saint maurice
Saint-Maurice, France, 94410
Actively Recruiting
Research Team
S
Sylvain Brochard, Pr
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here